PCRX vs IRWD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

PCRX

35.0
AI Score
VS
IRWD Wins

IRWD

66.8
AI Score

Investment Advisor Scores

PCRX

35score
Recommendation
SELL

IRWD

67score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PCRX IRWD Winner
Revenue 219.55M 369.77M PCRX
Net Income 92.06M 7.57M IRWD
Net Margin 41.9% 2.0% IRWD
Operating Income 151.88M 11.17M IRWD
ROE -56.9% 1.1% PCRX
ROA 32.3% 0.6% IRWD
Total Assets 285.13M 1.24B PCRX
Cash 79.13M 205.88M PCRX
Current Ratio 6.06 5.04 IRWD

Relative Price Performance (Last 90 Days)

PCRX 1M: +47.5% · 3M: +40.4% IRWD 1M: -16.4% · 3M: -3.8%

Current Technical Phase

PCRX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.8% over 20 days), RSI 84

RSI (14): 83.6 · Price: $36.34

IRWD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.5%), weak momentum, RSI 40

RSI (14): 40.5 · Price: $3.57

Fundamentals Snapshot

Metric PCRX IRWD
Market Cap — —
Forward P/E 10.5 2.4
Trailing P/E 103.8 4.6
Revenue (TTM) — —
Revenue Growth 0.1% 0.3%
Gross Margin 0.8% 0.8%
Operating Margin 0.1% 0.7%
EPS 0.35 0.77
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IRWD is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.